DK592186D0 - Fremgangsmaade til udvinding af proteiner - Google Patents

Fremgangsmaade til udvinding af proteiner

Info

Publication number
DK592186D0
DK592186D0 DK592186A DK592186A DK592186D0 DK 592186 D0 DK592186 D0 DK 592186D0 DK 592186 A DK592186 A DK 592186A DK 592186 A DK592186 A DK 592186A DK 592186 D0 DK592186 D0 DK 592186D0
Authority
DK
Denmark
Prior art keywords
proteins
source
cationic surfactant
solubilisation
protein
Prior art date
Application number
DK592186A
Other languages
English (en)
Other versions
DK171331B1 (da
DK592186A (da
Inventor
Malcolm Roy Brandon
Jeseph John Patroni
Original Assignee
Bunge Australia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bunge Australia filed Critical Bunge Australia
Publication of DK592186D0 publication Critical patent/DK592186D0/da
Publication of DK592186A publication Critical patent/DK592186A/da
Application granted granted Critical
Publication of DK171331B1 publication Critical patent/DK171331B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormones [GH] (Somatotropin)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials
DK592186A 1985-12-11 1986-12-10 Fremgangsmåde til solubilisering af proteiner DK171331B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPH381885 1985-12-11
AUPH381885 1985-12-11

Publications (3)

Publication Number Publication Date
DK592186D0 true DK592186D0 (da) 1986-12-10
DK592186A DK592186A (da) 1987-06-12
DK171331B1 DK171331B1 (da) 1996-09-09

Family

ID=3771404

Family Applications (1)

Application Number Title Priority Date Filing Date
DK592186A DK171331B1 (da) 1985-12-11 1986-12-10 Fremgangsmåde til solubilisering af proteiner

Country Status (14)

Country Link
US (1) US4797474A (da)
EP (1) EP0226448B1 (da)
JP (1) JPH0660198B2 (da)
CN (1) CN86108729A (da)
AT (1) ATE76878T1 (da)
AU (1) AU597924B2 (da)
CA (1) CA1281849C (da)
DE (1) DE3685562T2 (da)
DK (1) DK171331B1 (da)
ES (1) ES2032194T3 (da)
GR (1) GR3004903T3 (da)
MY (1) MY101204A (da)
NO (1) NO864990L (da)
NZ (1) NZ218586A (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
CA1305285C (en) * 1987-04-21 1992-07-14 Malcolm Roy Brandon Production of proteins in active forms
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5654176A (en) * 1987-05-28 1997-08-05 Amrad Corporation Limited Fusion proteins containing glutathione-s-transferase
AU609824B2 (en) * 1987-06-15 1991-05-09 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0295859B1 (en) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Production of proteins in active forms
US5266205A (en) * 1988-02-04 1993-11-30 Battelle Memorial Institute Supercritical fluid reverse micelle separation
US5637566A (en) * 1988-08-24 1997-06-10 Southern Cross Biotech Pty. Ltd. Method of improving carcass quality by administering growth hormone
US5136027A (en) * 1989-05-02 1992-08-04 Abbott Laboratories Method for renaturing proteins in the presence of alkyl sulfate detergents
EP0444441B1 (en) * 1990-03-01 1996-09-25 Hewlett-Packard Company Minimizing eluate band widths in liquid chromatography
US5530100A (en) * 1990-05-07 1996-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Methods for purification of recombinantly produced proteins
EP0529201B1 (en) * 1991-08-26 1997-09-24 Hewlett-Packard Company Chromatographic method with micellar on-column enrichment
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
AU729415B2 (en) 1996-07-12 2001-02-01 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
ZA9711733B (en) 1996-12-31 1998-07-01 Monsanto Co Method for solubilization and naturation of somatotropins
US20020052026A1 (en) 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
EP2158923B1 (en) 1998-08-06 2013-02-27 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
CA2504129A1 (en) * 2002-11-01 2004-05-21 Promega Corporation Cell lysis compositions, methods of use, apparatus, and kit
DE10309691B4 (de) 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
RU2435847C2 (ru) 2005-04-11 2011-12-10 Савиент Фармасьютикалз, Инк. Вариантная форма урат-оксидазы и ее использование
PL3321359T3 (pl) 2005-04-11 2021-06-28 Horizon Pharma Rheumatology Llc Wariantowe postacie oksydazy moczanowej i ich zastosowanie
WO2006125452A1 (en) * 2005-05-23 2006-11-30 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
ES2553153T3 (es) * 2005-12-14 2015-12-04 Denka Seiken Co., Ltd. Detección inmunocromatográfica de Staphylococcus multirresistente y kit de diagnóstico
ES2532804T3 (es) * 2006-04-12 2015-03-31 Crealta Pharmaceuticals Llc Purificación de proteínas con tensioactivo catiónico
EP2074223A4 (en) * 2006-09-15 2010-03-10 Foldrx Pharmaceuticals Inc TEST PROCEDURE FOR THE DETECTION OF PROTEINS IN THE NATIVE CONDITION AND FOR THE IDENTIFICATION OF THE STABILITY OF PROTEINS IN THE NATIVE CONDITION MODULATING COMPOUNDS
US8663725B2 (en) * 2007-10-05 2014-03-04 Advance International Inc. Method for deriving a high-protein powder/ omega 3 oil and double distilled water from any kind of fish or animal ( protein)
US9706787B2 (en) * 2007-10-05 2017-07-18 Advance International Inc. Systems and methods for deriving protein powder
KR101861547B1 (ko) 2009-06-25 2018-07-02 크레알타 파마슈티칼스 엘엘씨 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체­매개 상실을 예측하는 방법 및 키트
EP2855502B1 (en) * 2012-05-31 2019-06-26 Agency For Science, Technology And Research Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives
US9826757B2 (en) 2013-03-15 2017-11-28 Advance International Inc. Automated method and system for recovering protein powder meal, pure omega 3 oil and purified distilled water from animal tissue
JP6147340B2 (ja) * 2013-05-29 2017-06-14 Jsr株式会社 洗浄用組成物、タンパク質精製方法、及びタンパク質
SG11201607001PA (en) * 2014-02-27 2016-09-29 Agency Science Tech & Res Methods for reducing chromatin content in protein preparations by treatment with alkyl cations
JP6984828B2 (ja) * 2017-11-22 2021-12-22 学校法人東京薬科大学 凝集タンパク質の再生剤およびこれを用いた凝集タンパク質の再生方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides
US4659568A (en) * 1985-02-27 1987-04-21 American Cyanamid Company Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
US4656255A (en) * 1985-09-09 1987-04-07 International Minerals & Chemical Corp. Protein recovery
EP0317561B1 (en) * 1986-07-28 1991-01-30 AlliedSignal Inc. Sulfonate benzotriazoles and their use in polyamide

Also Published As

Publication number Publication date
NO864990L (no) 1987-06-12
DK171331B1 (da) 1996-09-09
CN86108729A (zh) 1987-10-21
DK592186A (da) 1987-06-12
US4797474A (en) 1989-01-10
EP0226448A3 (en) 1989-01-11
NO864990D0 (no) 1986-12-10
DE3685562T2 (de) 1992-12-24
AU6687486A (en) 1987-06-18
GR3004903T3 (da) 1993-04-28
MY101204A (en) 1991-08-17
JPS62223192A (ja) 1987-10-01
NZ218586A (en) 1989-07-27
CA1281849C (en) 1991-03-19
EP0226448B1 (en) 1992-06-03
AU597924B2 (en) 1990-06-14
ES2032194T3 (es) 1993-01-16
ATE76878T1 (de) 1992-06-15
JPH0660198B2 (ja) 1994-08-10
DE3685562D1 (de) 1992-07-09
EP0226448A2 (en) 1987-06-24

Similar Documents

Publication Publication Date Title
DK592186A (da) Fremgangsmaade til udvinding af proteiner
ES2109924T3 (es) Metodo rapido, versatil y simple de expresion de genes en celulas eucarioticas.
ATE110782T1 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
BR0010725A (pt) Expressão e exportação de proteìnas de interferon-alfa como proteìnas de fusão de fc
DE3786592T2 (de) Transformation von trichoderma.
DK322188A (da) Fremgangsmaade til fremstilling af protein
NZ320276A (en) Method and preparations for stabilizing biological materials by drying methods without freezing
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
DK430486D0 (da) Fremgangsmaade til udvinding af protein
SE8703225L (sv) Monoklonala antikroppar och peptider anvendbara vid behandling och diagnostisering av hiv-infektioner
ES8706208A1 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia
ES8604990A1 (es) Procedimiento para la inactivacion de sustancias que provocan reacciones de incompatibilidad en productos sanguineos
Hovanessian et al. Protein kinase in human plasma analogous to that present in control and interferon-treated HeLa cells
DE3587205D1 (de) Verfahren zur herstellung eines proteins und dafuer zu verwendender vektor, rekombinante dns und transformierte zelle.
AU1948788A (en) Expression of immunologically active proteins of human b-lymphotropic virus
SE8901715L (sv) En plasmid dna-konstruktion innehaallande dna-sekvenser
ORANSKII et al. Optimization of medicinal electrophoresis(enhancement of cutaneous penetration)
Gen et al. Enhancement of Growth of Bluetongue Viruses in Cell Cultures through Trypsin Treatment
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози
DK107493A (da) Vektor for udtrykkelse i gaer, bestaaende af et fremmed dna-segment og en fremgangsmaade til syntese af fremmede proteiner ved hjaelp af en saadan vektor

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
B1 Patent granted (law 1993)
PUP Patent expired